Tag: allergy diagnostics industry

  • Allergy Diagnostics Market Expected To Reach $13.02 Billion By 2030 As Growth Accelerates At 13.2% CAGR

    Allergy Diagnostics Market Expected To Reach $13.02 Billion By 2030 As Growth Accelerates At 13.2% CAGR

    Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

    Allergy Diagnostics Market Expansion Outlook: What Revenue Opportunities Lie Ahead?

    The sector dedicated to allergy diagnostics has experienced a significant upswing lately. Projections indicate a rise from a valuation of $6.99 billion in 2025 to $7.94 billion by 2026, reflecting a compound annual growth rate of 13.5%. Factors contributing to this expansion during the preceding period include the escalating incidence of allergic conditions globally, a greater uptake of skin prick and intradermal testing methodologies, the proliferation of laboratory facilities within hospital settings, heightened public consciousness regarding allergy management strategies, and the constrained accessibility of sophisticated in-vitro testing kits.

    The global market for allergy diagnostics is poised for substantial expansion over the coming years, projecting a reach of $13.03 billion by 2030, driven by a compound annual growth rate of 13.2%. This anticipated surge is a direct result of several key factors, including advancements in component-resolved diagnostics, the increasing integration of automated systems in allergy testing procedures, heightened investments in exploring novel allergens through research initiatives, the proliferation of academic and diagnostic laboratories, and a growing consumer desire for tailored allergy treatment plans. Throughout this forecast period, dominant trends will include a persistent demand for highly accurate diagnostic solutions, a widening embrace of in-vitro testing methodologies, the continuous expansion of food and drug allergen assessments, a more extensive utilization of ELISA, RAST, and CRD kits, and a pronounced focus on developing rapid, point-of-care allergy detection methods.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5655&type=smp

    #Allergy Diagnostics Market Growth Drivers And Industry Catalysts

    The escalating incidence of allergic conditions is set to be a significant driver for the expansion of the allergy diagnostics market, with environmental factors such as industrial and vehicular emissions being key contributors to this upward trend in allergy prevalence, whereas an allergic reaction itself is characterized by an aberrant immune system reaction to a specific allergen, encompassing a range of conditions including anaphylaxis, allergic rhinitis commonly known as ‘hay fever,’ sensitivities to food, skin reactions, and allergic asthma, and the primary strategy for managing these allergic disorders involves stringent avoidance of the triggering allergen, underscoring the criticality of accurate allergy diagnosis for successful therapeutic interventions, for example, Anaphylaxis UK, a UK charity, reported in September 2024 that food allergy reactions manifest in school settings 20% of the time, with a concerning statistic of one in five children with food allergies facing bullying and an equivalent proportion of parents experiencing moderate to extreme anxiety, furthermore, nearly all parents of children with allergies exhibit symptoms of post-traumatic stress symptoms (PTSS), a rate sevenfold higher among those whose children require adrenaline auto-injectors (AAIs), consequently, the growing prevalence of allergic diseases will undoubtedly bolster the growth trajectory of the allergic diagnostics market.

    Allergy Diagnostics Market Segment Breakdown: Which Categories Generate The Most Revenue?

    The allergy diagnostics market covered in this report is segmented –

    1) By Test Type: In-Vivo Allergy Tests, In-Vitro Allergy Tests

    2) By Allergen: Inhaled Allergens, Food Allergens, Drug Allergens

    3) By Products: Consumables, Instruments

    4) By End User: Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes

    Subsegments:

    1) By In-Vivo Allergy Tests: Skin Prick Tests, Intradermal Tests, Patch Tests, Oral Food Challenge Tests

    2) By In-Vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Radioallergosorbent Test (RAST), Component-Resolved Diagnostics (CRD), Basophil Activation Tests (BAT)

    #Allergy Diagnostics Market Trends Influencing Long-Term Demand

    Leading entities within the allergy diagnostics sector are actively pursuing novel technological advancements, exemplified by an AI-driven platform for allergy component analysis, as a strategy to enhance their market profitability. This sophisticated system leverages artificial intelligence to meticulously examine and interpret the outcomes of allergy testing. As a concrete illustration, Metropolis, a diagnostic provider situated in India, introduced in May 2023 an AI-powered allergy component testing solution capable of identifying 127 airborne allergens, 10 allergens causing skin reactions, and 158 food-related allergens, thereby offering profound insights for tailoring and refining patient treatment plans and assisting healthcare professionals in making informed clinical judgments through the integration of component-resolved diagnostics and artificial intelligence.

    Allergy Diagnostics Market Key Players And Strategic Industry Positioning

    Major companies operating in the allergy diagnostics market are bioMérieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Stallergenes Greer, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Eurofins Viracor Inc., VRL Laboratories

    Access The Complete Allergy Diagnostics Market Report:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    Allergy Diagnostics Market Leading Geography: Which Region Generates The Most Revenue?

    North America was the largest region in the allergy diagnostics market in 2025. The regions covered in the allergy diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Allergy Diagnostics Market: Developments Driving Growth

    Allergy Diagnostics Market: Developments Driving Growth

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Are The Market Size Estimates For The Allergy Diagnostics Market In 2026 And 2030?

    The allergy diagnostics market size has seen rapid expansion in recent years. It is anticipated to increase from $6.99 billion in 2025 to $7.94 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.5%. The historical growth of this market can be ascribed to the rising global incidence of allergies, the adoption of skin prick and intradermal tests, the expansion of hospital-based laboratories, increasing awareness regarding allergy management, and the limited availability of advanced in-vitro kits.

    The allergy diagnostics market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $13.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.2%. Several factors contribute to this growth during the forecast period, including progress in component-resolved diagnostics, the incorporation of automation into allergy testing, increased funding for research into new allergens, the proliferation of academic and diagnostic laboratories, and a rising need for individualized allergy treatment. Key trends expected during the forecast period encompass an escalating need for precise allergy diagnostics, the increasing acceptance of in-vitro testing techniques, broader application of food and drug allergen testing, enhanced utilization of ELISA, RAST, and CRD kits, and an emphasis on swift and point-of-care allergy detection.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    What Significant Factors Are Influencing The Allergy Diagnostics Market Expansion?

    The escalating prevalence of allergic diseases is set to drive the expansion of the allergy diagnostics market. This increase in allergic conditions has been attributed to heightened environmental pollution stemming from traffic and various industries. An allergic reaction is defined as an abnormal immune system response to a specific allergen. Allergy diseases encompass anaphylaxis, allergic rhinitis (frequently referred to as ‘hay fever’), food allergies, skin allergies, and allergic asthma. The most crucial treatment for allergic disorders involves avoiding the allergen; therefore, accurate allergy diagnosis is essential for effective allergy treatment. For instance, in September 2024, data from Anaphylaxis UK, a UK-based charity, revealed that 20% of food allergy reactions occur at school. One in five children with food allergies experience bullying, and one in five parents report moderate-to-extreme anxiety. Nearly all parents of affected children exhibit post-traumatic stress symptoms (PTSS), with rates seven times higher among those whose children use adrenaline auto-injectors (AAIs). Consequently, the growing incidence of allergic diseases will further support the growth of the allergic diagnostics market.

    Which Segments Define The Allergy Diagnostics Market Segment Structure?

    The allergy diagnostics market covered in this report is segmented –

    1) By Test Type: In-Vivo Allergy Tests, In-Vitro Allergy Tests

    2) By Allergen: Inhaled Allergens, Food Allergens, Drug Allergens

    3) By Products: Consumables, Instruments

    4) By End User: Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes

    Subsegments:

    1) By In-Vivo Allergy Tests: Skin Prick Tests, Intradermal Tests, Patch Tests, Oral Food Challenge Tests

    2) By In-Vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Radioallergosorbent Test (RAST), Component-Resolved Diagnostics (CRD), Basophil Activation Tests (BAT)

    What Trends Are Affecting The Direction Of The Allergy Diagnostics Market?

    Major enterprises operating within the allergy diagnostics market are developing new technologies, including an AI-powered allergy component testing platform, to enhance their market profitability. An AI-powered allergy component testing platform functions as an advanced system employing artificial intelligence (AI) to interpret and analyze allergy testing outcomes. As an illustration, in May 2023, Metropolis, an India-based pathology lab and diagnostic center, launched an artificial intelligence (AI)-driven platform for allergy component testing that can identify 127 respiratory allergens, 10 contact allergens, and 158 food allergens. This testing platform furnishes extensive knowledge for establishing and refining an individual’s allergy treatment plan and assists clinicians in formulating informed clinical decisions by leveraging component-resolved diagnostics (CRD) and artificial intelligence (AI).

    Who Are The Established Players Within The Allergy Diagnostics Market?

    Major companies operating in the allergy diagnostics market are bioMérieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Stallergenes Greer, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Eurofins Viracor Inc., VRL Laboratories

    Get The Full Allergy Diagnostics Market Report:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    Which Region Is The Largest In The Allergy Diagnostics Market?

    North America was the largest region in the allergy diagnostics market in 2025. The regions covered in the allergy diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Allergy Diagnostics Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    Browse Through More Reports Similar to the Global Allergy Diagnostics Market 2026, By The Business Research Company

    Immunoglobulin E Ige Allergy Blood Tests Market Report 2026

    https://www.thebusinessresearchcompany.com/report/immunoglobulin-e-ige-allergy-blood-tests-global-market-report

    Allergy Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

    Allergy Immunotherapy Market Report 2026

    https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Allergy Diagnostics Market: Developments Driving Growth

    Allergy Diagnostics Market: Developments Driving Growth

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Are The Market Size Estimates For The Allergy Diagnostics Market In 2026 And 2030?

    The allergy diagnostics market size has seen rapid expansion in recent years. It is anticipated to increase from $6.99 billion in 2025 to $7.94 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.5%. The historical growth of this market can be ascribed to the rising global incidence of allergies, the adoption of skin prick and intradermal tests, the expansion of hospital-based laboratories, increasing awareness regarding allergy management, and the limited availability of advanced in-vitro kits.

    The allergy diagnostics market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $13.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.2%. Several factors contribute to this growth during the forecast period, including progress in component-resolved diagnostics, the incorporation of automation into allergy testing, increased funding for research into new allergens, the proliferation of academic and diagnostic laboratories, and a rising need for individualized allergy treatment. Key trends expected during the forecast period encompass an escalating need for precise allergy diagnostics, the increasing acceptance of in-vitro testing techniques, broader application of food and drug allergen testing, enhanced utilization of ELISA, RAST, and CRD kits, and an emphasis on swift and point-of-care allergy detection.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    What Significant Factors Are Influencing The Allergy Diagnostics Market Expansion?

    The escalating prevalence of allergic diseases is set to drive the expansion of the allergy diagnostics market. This increase in allergic conditions has been attributed to heightened environmental pollution stemming from traffic and various industries. An allergic reaction is defined as an abnormal immune system response to a specific allergen. Allergy diseases encompass anaphylaxis, allergic rhinitis (frequently referred to as ‘hay fever’), food allergies, skin allergies, and allergic asthma. The most crucial treatment for allergic disorders involves avoiding the allergen; therefore, accurate allergy diagnosis is essential for effective allergy treatment. For instance, in September 2024, data from Anaphylaxis UK, a UK-based charity, revealed that 20% of food allergy reactions occur at school. One in five children with food allergies experience bullying, and one in five parents report moderate-to-extreme anxiety. Nearly all parents of affected children exhibit post-traumatic stress symptoms (PTSS), with rates seven times higher among those whose children use adrenaline auto-injectors (AAIs). Consequently, the growing incidence of allergic diseases will further support the growth of the allergic diagnostics market.

    Which Segments Define The Allergy Diagnostics Market Segment Structure?

    The allergy diagnostics market covered in this report is segmented –

    1) By Test Type: In-Vivo Allergy Tests, In-Vitro Allergy Tests

    2) By Allergen: Inhaled Allergens, Food Allergens, Drug Allergens

    3) By Products: Consumables, Instruments

    4) By End User: Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes

    Subsegments:

    1) By In-Vivo Allergy Tests: Skin Prick Tests, Intradermal Tests, Patch Tests, Oral Food Challenge Tests

    2) By In-Vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Radioallergosorbent Test (RAST), Component-Resolved Diagnostics (CRD), Basophil Activation Tests (BAT)

    What Trends Are Affecting The Direction Of The Allergy Diagnostics Market?

    Major enterprises operating within the allergy diagnostics market are developing new technologies, including an AI-powered allergy component testing platform, to enhance their market profitability. An AI-powered allergy component testing platform functions as an advanced system employing artificial intelligence (AI) to interpret and analyze allergy testing outcomes. As an illustration, in May 2023, Metropolis, an India-based pathology lab and diagnostic center, launched an artificial intelligence (AI)-driven platform for allergy component testing that can identify 127 respiratory allergens, 10 contact allergens, and 158 food allergens. This testing platform furnishes extensive knowledge for establishing and refining an individual’s allergy treatment plan and assists clinicians in formulating informed clinical decisions by leveraging component-resolved diagnostics (CRD) and artificial intelligence (AI).

    Who Are The Established Players Within The Allergy Diagnostics Market?

    Major companies operating in the allergy diagnostics market are bioMérieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Stallergenes Greer, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Eurofins Viracor Inc., VRL Laboratories

    Get The Full Allergy Diagnostics Market Report:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    Which Region Is The Largest In The Allergy Diagnostics Market?

    North America was the largest region in the allergy diagnostics market in 2025. The regions covered in the allergy diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Allergy Diagnostics Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    Browse Through More Reports Similar to the Global Allergy Diagnostics Market 2026, By The Business Research Company

    Immunoglobulin E Ige Allergy Blood Tests Market Report 2026

    https://www.thebusinessresearchcompany.com/report/immunoglobulin-e-ige-allergy-blood-tests-global-market-report

    Allergy Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

    Allergy Immunotherapy Market Report 2026

    https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Allergy Diagnostics Market: Developments Driving Growth

    Allergy Diagnostics Market: Developments Driving Growth

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Are The Market Size Estimates For The Allergy Diagnostics Market In 2026 And 2030?

    The allergy diagnostics market size has seen rapid expansion in recent years. It is anticipated to increase from $6.99 billion in 2025 to $7.94 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.5%. The historical growth of this market can be ascribed to the rising global incidence of allergies, the adoption of skin prick and intradermal tests, the expansion of hospital-based laboratories, increasing awareness regarding allergy management, and the limited availability of advanced in-vitro kits.

    The allergy diagnostics market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $13.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.2%. Several factors contribute to this growth during the forecast period, including progress in component-resolved diagnostics, the incorporation of automation into allergy testing, increased funding for research into new allergens, the proliferation of academic and diagnostic laboratories, and a rising need for individualized allergy treatment. Key trends expected during the forecast period encompass an escalating need for precise allergy diagnostics, the increasing acceptance of in-vitro testing techniques, broader application of food and drug allergen testing, enhanced utilization of ELISA, RAST, and CRD kits, and an emphasis on swift and point-of-care allergy detection.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    What Significant Factors Are Influencing The Allergy Diagnostics Market Expansion?

    The escalating prevalence of allergic diseases is set to drive the expansion of the allergy diagnostics market. This increase in allergic conditions has been attributed to heightened environmental pollution stemming from traffic and various industries. An allergic reaction is defined as an abnormal immune system response to a specific allergen. Allergy diseases encompass anaphylaxis, allergic rhinitis (frequently referred to as ‘hay fever’), food allergies, skin allergies, and allergic asthma. The most crucial treatment for allergic disorders involves avoiding the allergen; therefore, accurate allergy diagnosis is essential for effective allergy treatment. For instance, in September 2024, data from Anaphylaxis UK, a UK-based charity, revealed that 20% of food allergy reactions occur at school. One in five children with food allergies experience bullying, and one in five parents report moderate-to-extreme anxiety. Nearly all parents of affected children exhibit post-traumatic stress symptoms (PTSS), with rates seven times higher among those whose children use adrenaline auto-injectors (AAIs). Consequently, the growing incidence of allergic diseases will further support the growth of the allergic diagnostics market.

    Which Segments Define The Allergy Diagnostics Market Segment Structure?

    The allergy diagnostics market covered in this report is segmented –

    1) By Test Type: In-Vivo Allergy Tests, In-Vitro Allergy Tests

    2) By Allergen: Inhaled Allergens, Food Allergens, Drug Allergens

    3) By Products: Consumables, Instruments

    4) By End User: Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes

    Subsegments:

    1) By In-Vivo Allergy Tests: Skin Prick Tests, Intradermal Tests, Patch Tests, Oral Food Challenge Tests

    2) By In-Vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Radioallergosorbent Test (RAST), Component-Resolved Diagnostics (CRD), Basophil Activation Tests (BAT)

    What Trends Are Affecting The Direction Of The Allergy Diagnostics Market?

    Major enterprises operating within the allergy diagnostics market are developing new technologies, including an AI-powered allergy component testing platform, to enhance their market profitability. An AI-powered allergy component testing platform functions as an advanced system employing artificial intelligence (AI) to interpret and analyze allergy testing outcomes. As an illustration, in May 2023, Metropolis, an India-based pathology lab and diagnostic center, launched an artificial intelligence (AI)-driven platform for allergy component testing that can identify 127 respiratory allergens, 10 contact allergens, and 158 food allergens. This testing platform furnishes extensive knowledge for establishing and refining an individual’s allergy treatment plan and assists clinicians in formulating informed clinical decisions by leveraging component-resolved diagnostics (CRD) and artificial intelligence (AI).

    Who Are The Established Players Within The Allergy Diagnostics Market?

    Major companies operating in the allergy diagnostics market are bioMérieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Stallergenes Greer, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Eurofins Viracor Inc., VRL Laboratories

    Get The Full Allergy Diagnostics Market Report:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    Which Region Is The Largest In The Allergy Diagnostics Market?

    North America was the largest region in the allergy diagnostics market in 2025. The regions covered in the allergy diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Allergy Diagnostics Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    Browse Through More Reports Similar to the Global Allergy Diagnostics Market 2026, By The Business Research Company

    Immunoglobulin E Ige Allergy Blood Tests Market Report 2026

    https://www.thebusinessresearchcompany.com/report/immunoglobulin-e-ige-allergy-blood-tests-global-market-report

    Allergy Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

    Allergy Immunotherapy Market Report 2026

    https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Allergy Diagnostics Market Global Report 2026 Market Expected to Record Steady Growth and Approach $13.02 Billion by 2030

    Allergy Diagnostics Market Global Report 2026 Market Expected to Record Steady Growth and Approach $13.02 Billion by 2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Valuation Is Forecasted For The Allergy Diagnostics Market By 2030 Starting From Its 2026 Size?

    The allergy diagnostics market has experienced substantial expansion in recent years. Its size is projected to increase from $6.99 billion in 2025 to $7.94 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.5%. The historical growth of this market is attributable to factors such as the increasing global prevalence of allergies, the widespread adoption of skin prick and intradermal tests, the expansion of hospital-based laboratories, a rising awareness regarding allergy management, and the limited availability of advanced in-vitro kits.

    The allergy diagnostics market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $13.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.2%. This projected increase during the forecast period stems from factors such as progress in component-resolved diagnostics, the incorporation of automation into allergy testing procedures, escalating investment in discovering new allergens, the proliferation of academic and diagnostic laboratory facilities, and the rising need for customized allergy management. Key developments expected throughout this period encompass an increasing need for precise allergy diagnostics, the expanding acceptance of in-vitro testing approaches, the broadening scope of food and drug allergen assessments, enhanced utilization of ELISA, RAST, and CRD kits, and a heightened emphasis on swift, point-of-care allergy identification methods.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5655&type=smp

    What Drivers Are Shaping The Future Growth Of The Allergy Diagnostics Market?

    The growing frequency of allergic conditions is expected to drive the expansion of the allergy diagnostics market. This increase in allergy ailments is linked to heightened environmental contamination stemming from vehicle emissions and various industrial activities. An allergic response is defined as an unusual reaction by the immune system when exposed to an allergen. Such conditions encompass anaphylaxis, allergic rhinitis (commonly known as ‘hay fever’), food allergies, skin allergies, and allergic asthma. For allergic disorders, the most crucial therapeutic approach involves avoiding the specific allergen. Consequently, an accurate allergy diagnosis becomes vital for successful allergy treatment. For example, data from September 2024, provided by Anaphylaxis UK, a charity based in the UK, indicates that 20% of food allergy incidents happen in educational settings. It was also noted that one in five children affected by food allergies face bullying, and one in five parents experience anxiety ranging from moderate to extreme. Furthermore, almost all parents of children with these allergies show symptoms of post-traumatic stress (PTSS), with the incidence being seven times greater for those whose children rely on adrenaline auto-injectors (AAIs). Therefore, the expanding prevalence of allergic conditions is set to further bolster the growth of the allergic diagnostics market.

    Which Segment Categories Define The Allergy Diagnostics Market?

    The allergy diagnostics market covered in this report is segmented –

    1) By Test Type: In-Vivo Allergy Tests, In-Vitro Allergy Tests

    2) By Allergen: Inhaled Allergens, Food Allergens, Drug Allergens

    3) By Products: Consumables, Instruments

    4) By End User: Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes

    Subsegments:

    1) By In-Vivo Allergy Tests: Skin Prick Tests, Intradermal Tests, Patch Tests, Oral Food Challenge Tests

    2) By In-Vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Radioallergosorbent Test (RAST), Component-Resolved Diagnostics (CRD), Basophil Activation Tests (BAT)

    What Major Market Trends Are Driving Changes In The Allergy Diagnostics Market?

    Leading companies within the allergy diagnostics market are developing novel technologies, including AI-driven allergy component testing platforms, to boost their profitability. An AI-powered allergy component testing platform signifies an advanced technological system that utilizes artificial intelligence (AI) to analyze and interpret allergy testing outcomes. For example, in May 2023, Metropolis, an India-based pathology lab and diagnostic center, unveiled an artificial intelligence (AI)-powered platform for testing allergy components, which is proficient in identifying 127 respiratory allergens, 10 contact allergens, and 158 food allergens. This platform offers valuable understanding for determining and optimizing treatment approaches for an individual’s allergy condition, thereby supporting clinicians in making astute clinical decisions by integrating component-resolved diagnostics (CRD) and artificial intelligence (AI).

    Who Are The Top Companies Competing In The Allergy Diagnostics Market?

    Major companies operating in the allergy diagnostics market are bioMérieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Stallergenes Greer, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Eurofins Viracor Inc., VRL Laboratories

    Read the full allergy diagnostics market report here:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    Which Geographic Regions Are Influencing Demand In The Allergy Diagnostics Market?

    North America was the largest region in the allergy diagnostics market in 2025. The regions covered in the allergy diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Allergy Diagnostics Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=5655&type=smp

    Browse Through More Reports Similar to the Global Allergy Diagnostics Market 2026, By The Business Research Company

    allergy treatment global market report

    https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

    allergy immunotherapy global market report

    https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

    immunoglobulin e ige allergy blood tests global market report

    https://www.thebusinessresearchcompany.com/report/immunoglobulin-e-ige-allergy-blood-tests-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Allergy Diagnostics Industry Trends and Market Forecast 2026–2030

    Global Allergy Diagnostics Industry Trends and Market Forecast 2026–2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the allergy diagnostics market from 2026–2035 with trusted insights from The Business Research Company

    What market expansion outlook does the Allergy Diagnostics Market show for the 2026–2030 period?

    The allergy diagnostics market size has observed rapid expansion in recent years. It is anticipated to grow from $6.99 billion in 2025 to $7.94 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.5%. The past growth can be ascribed to several factors, including the increasing prevalence of allergies worldwide, the adoption of skin prick and intradermal tests, the expansion of hospital-based laboratories, growing awareness about allergy management, and the limited availability of advanced in-vitro kits.

    The allergy diagnostics market is projected to experience substantial growth over the next few years, with its size anticipated to reach $13.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.2%. This expansion during the forecast period is attributed to advancements in component-resolved diagnostics, the incorporation of automation into allergy testing, increased investment in research on novel allergens, the proliferation of academic and diagnostic laboratories, and a rising demand for personalized allergy treatment. Major trends anticipated in this period include an increasing need for accurate allergy diagnostics, the growing adoption of in-vitro testing methods, the broadening scope of food and drug allergen testing, enhanced utilization of ELISA, RAST, and CRD kits, and a strategic focus on rapid and point-of-care allergy detection.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5655&type=smp

    What Drivers Are Shaping The Development Of The Allergy Diagnostics Market?

    The escalating incidence of allergic conditions is set to drive the expansion of the allergy diagnostics market. This surge in allergies is linked to elevated environmental pollution stemming from vehicular traffic and various industrial activities. An allergic reaction is defined as an atypical response of the immune system when exposed to an allergen. Examples of allergic diseases encompass anaphylaxis, allergic rhinitis (commonly known as ‘hay fever’), food allergies, skin allergies, and allergic asthma. The primary treatment for allergic conditions involves avoiding the specific allergen. Consequently, accurate allergy diagnosis becomes vital for successful allergy management. For example, data from Anaphylaxis UK, a charity in the UK, indicated in September 2024 that 20% of food allergy reactions happen in school settings. Furthermore, one in five children affected by food allergies face bullying, and one in five parents experience moderate-to-extreme anxiety. Almost all parents of children with allergies show symptoms of post-traumatic stress (PTSS), with these rates being seven times higher for parents whose children rely on adrenaline auto-injectors (AAIs). Therefore, the increasing prevalence of allergic diseases is expected to further bolster the expansion of the allergic diagnostics market.

    What Segment Types Are Examined In The Allergy Diagnostics Market?

    The allergy diagnostics market covered in this report is segmented –

    1) By Test Type: In-Vivo Allergy Tests, In-Vitro Allergy Tests

    2) By Allergen: Inhaled Allergens, Food Allergens, Drug Allergens

    3) By Products: Consumables, Instruments

    4) By End User: Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes

    Subsegments:

    1) By In-Vivo Allergy Tests: Skin Prick Tests, Intradermal Tests, Patch Tests, Oral Food Challenge Tests

    2) By In-Vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Radioallergosorbent Test (RAST), Component-Resolved Diagnostics (CRD), Basophil Activation Tests (BAT)

    How Are Emerging Trends Affecting The Progression Of The Allergy Diagnostics Market?

    Leading companies in the allergy diagnostics market are developing innovative technologies, such as an AI-powered allergy component testing platform, to enhance their market profitability. Such a platform is a highly advanced system that uses artificial intelligence (AI) to interpret and analyze allergy testing outcomes. For instance, in May 2023, Metropolis, an India-based pathology lab and diagnostic center, introduced an AI-driven platform for testing allergy components, which can identify 127 respiratory allergens, 10 contact allergens, and 158 food allergens. This testing platform offers substantial information for establishing and optimizing an individual’s allergy treatment plan, enabling clinicians to make astute clinical decisions by leveraging component-resolved diagnostics (CRD) and artificial intelligence (AI).

    Who Are The Top-Performing Companies In The Allergy Diagnostics Market In Recent Years?

    Major companies operating in the allergy diagnostics market are bioMérieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Stallergenes Greer, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Eurofins Viracor Inc., VRL Laboratories

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    Which Region Currently Holds The Largest Share Of The Allergy Diagnostics Market?

    North America was the largest region in the allergy diagnostics market in 2025. The regions covered in the allergy diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Allergy Diagnostics Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=5655&type=smp

    Browse Through More Reports Similar to the Global Allergy Diagnostics Market 2026, By The Business Research Company

    Immunoglobulin E Ige Allergy Blood Tests Market Report 2026

    https://www.thebusinessresearchcompany.com/report/immunoglobulin-e-ige-allergy-blood-tests-global-market-report

    Allergy Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

    Allergy Immunotherapy Market Report 2026

    https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • What Is The Forecast Valuation Of The Global Allergy Diagnostics Market Projected To Reach $11.54 Billion By 2029?

    What Is The Forecast Valuation Of The Global Allergy Diagnostics Market Projected To Reach $11.54 Billion By 2029?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    How Big Is The Allergy Diagnostics Market Today And What Is Its Future Size?

    The market size of allergy diagnostics has expanded swiftly over the last few years. It is predicted to rise from $6.32 billion in 2024 to $6.99 billion in 2025, illustrating a compound annual growth rate (CAGR) of 10.7%. The historic progression is ascribed to an increase in allergy occurrences, funding in allergy diagnostics research and development, alterations in dietary patterns and environmental determinants, governmental initiatives, and escalating demands for personalized medicine.

    The market size for allergy diagnostics is forecasted to experience a swift expansion in the upcoming years. The market is projected to surge to $11.54 billion by 2029 with a compound annual growth rate (CAGR) of 13.3%. The growth during this forecast period is slated to reflect various elements such as economic growth, enlargement of healthcare infrastructure, an increase in the aging population, an increased focus on early diagnosis and preventive measures. Significant trends set to shape the forecast period include molecular allergy diagnostics, personalized allergen profiling, at-home allergy testing kits, the incorporation of artificial intelligence (AI), telemedicine, and remote consultations for allergies.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5655&type=smp

    Which Key Factors Are Fueling Growth In The Allergy Diagnostics Market?

    The allergy diagnostics market is expected to grow due to a surge in allergic diseases, which is linked to increased pollution from traffic and multiple industries. An allergic reaction is essentially an unusual response by the immune system to an allergen. Allergic illnesses comprise anaphylaxis, allergic rhinitis or ‘hay fever,’ food allergies, skin allergies, and allergic asthma. Allergen avoidance is a critical aspect of the treatment for allergic conditions, hence the necessity for accurate allergy diagnosis for the effective management of these disorders. For instance, the American College of Allergy, Asthma, and Immunology (ACAAI) revealed that asthma and allergic diseases are prevalent across all age groups in the U.S. Asthma affects 24 million people, including over 6 million children. Allergies were identified as the 6th leading cause of sickness, with costs estimated to be around $18 million more. Over 50 million Americans are reported to suffer from allergies every year. This growing prevalence of allergic diseases is predicted to further reinforce the expansion of the allergy diagnostics market.

    How Is The Allergy Diagnostics Market Segmented Across Key Categories?

    The allergy diagnosticsmarket covered in this report is segmented –

    1) By Test Type: In-vivo Allergy Tests; In-vitro Allergy Tests

    2) By Allergen: Inhaled Allergens; Food Allergens; Drug Allergens

    3) By Products: Consumables; Instruments; Luminometers

    4) By End User: Diagnostics Laboratories; Hospital-based Laboratories; Academic and Research Institutes

    Subsegments:

    1) By In-vivo Allergy Tests: Skin Prick Tests; Intradermal Tests; Patch Tests; Oral Food Challenge Tests

    2) By In-vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA); Radioallergosorbent Test (RAST); Component-Resolved Diagnostics (CRD); Basophil Activation Tests (BAT)

    What Key Trends Are Driving Growth In The Allergy Diagnostics Market?

    The increase in alliances and strategic partnerships between companies in the allergy diagnostics sector to develop novel diagnostic methods or enhance the ones currently in use is an emerging trend in this market. For example, in August 2022, the U.S telehealth firm, LifeMD, declared a strategic alliance between its fully-owned subsidiary, Cleared, and Allergenis, a predictive data analytics company based in the U.S. The main objective of this partnership is to utilize Cleared’s telehealth capabilities in allergy and allergenis’ peanut allergy diagnostic blood test within the direct-to-consumer channel.

    Who Are The Leading Companies Driving The Allergy Diagnostics Market?

    Major companies operating in the allergy diagnostics market include BioMerieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC., Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Alcon Laboratories Inc., Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Astra Biotech GmbH, Stallergenes Greer, Diagenics Limited, DST Diagnostische Systeme & Technologien GmbH, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Microtest Laboratories Inc., Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Symbiotix Biotherapies Inc., Eurofins Viracor Inc., VRL Laboratories

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    Which Region Dominates The Allergy Diagnostics Market Today?

    North America was the largest region in the allergy diagnostics market in 2024. The regions covered in the allergy diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=5655&type=smp

    Browse Through More Reports Similar to the Global Allergy Diagnostics Market 2025, By The Business Research Company

    Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

    Diagnostic Equipment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

    Antimicrobial Susceptibility Testing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/antimicrobial-susceptibility-testing-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Allergy Diagnostics Industry Trends: Where the Market Is Headed by 2029

    Global Allergy Diagnostics Industry Trends: Where the Market Is Headed by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    How Much Was The Allergy Diagnostics Market Worth In 2025, And What Is Its Anticipated Value By 2029?

    The allergy diagnostics market has seen substantial growth in recent years. It is anticipated to expand from $6.32 billion in 2024 to $6.99 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.7%. The historical increase in this market can be linked to factors such as a rise in the prevalence of allergies, investments in research and development of allergy diagnostics, shifts in dietary habits and environmental factors, government initiatives, and an escalating demand for personalized medicine.

    The allergy diagnostics market is projected for significant expansion over the coming years. It is anticipated to reach $11.54 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 13.3%. Factors driving this growth during the forecast period include economic progress, an expanding healthcare infrastructure, an increasing aging population, and a heightened focus on early diagnosis and prevention. Key trends anticipated within this period encompass molecular allergy diagnostics, personalized allergen profiles, at-home allergy testing kits, the incorporation of artificial intelligence (AI), telemedicine, and virtual allergy consultations.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5655&type=smp

    What Are The Key Drivers Of Growth In The Allergy Diagnostics Market?

    The escalating incidence of allergic conditions is set to fuel expansion within the allergy diagnostics market. This surge in allergies is linked to heightened environmental pollution stemming from vehicular traffic and various industrial activities. An allergic reaction itself constitutes an atypical immune system response when exposed to a specific allergen. Such conditions encompass anaphylaxis, allergic rhinitis (commonly known as ‘hay fever’), various food allergies, skin allergies, and allergic asthma. The primary method for managing allergic disorders involves avoiding the identified allergen. Consequently, accurate allergy diagnosis becomes indispensable for administering successful treatment. For example, data from the American College of Allergy, Asthma, and Immunology (ACAAI) indicates that asthma and allergic ailments were prevalent across all age demographics in the US. In the US, asthma impacted 24 million individuals, a figure that included over 6 million children. Allergies ranked as the 6th leading cause of illness, incurring approximately $18 million in additional expenses. Annually, more than 50 million Americans experience allergies. Therefore, the increasing prevalence of allergic diseases will continue to bolster the growth of the allergy diagnostics market.

    What Are The Key Segments In The Allergy Diagnostics Market?

    The allergy diagnosticsmarket covered in this report is segmented –

    1) By Test Type: In-vivo Allergy Tests; In-vitro Allergy Tests

    2) By Allergen: Inhaled Allergens; Food Allergens; Drug Allergens

    3) By Products: Consumables; Instruments; Luminometers

    4) By End User: Diagnostics Laboratories; Hospital-based Laboratories; Academic and Research Institutes

    Subsegments:

    1) By In-vivo Allergy Tests: Skin Prick Tests; Intradermal Tests; Patch Tests; Oral Food Challenge Tests

    2) By In-vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA); Radioallergosorbent Test (RAST); Component-Resolved Diagnostics (CRD); Basophil Activation Tests (BAT)

    What Are The Major Trends Driving The Growth Of The Allergy Diagnostics Market?

    A notable recent trend in the allergy diagnostics industry is the growing number of collaborations and partnerships among companies, with the aim of inventing new testing methods or improving existing ones. For instance, in August 2022, LifeMD, a US-based telehealth company, announced a strategic partnership between its wholly-owned subsidiary, Cleared, and Allergenis, a US-based predictive data analytics company. This strategic partnership is intended to leverage Cleared’s allergy telehealth expertise and Allergenis’ peanut allergy diagnostic blood test in the direct-to-customer channel.

    Who Are The Major Companies Operating In The Allergy Diagnostics Market?

    Major companies operating in the allergy diagnostics market include BioMerieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC., Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Alcon Laboratories Inc., Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Astra Biotech GmbH, Stallergenes Greer, Diagenics Limited, DST Diagnostische Systeme & Technologien GmbH, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Microtest Laboratories Inc., Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Symbiotix Biotherapies Inc., Eurofins Viracor Inc., VRL Laboratories

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    Which Region Is Expected To Witness The Fastest Growth In The Allergy Diagnostics Market?

    North America was the largest region in the allergy diagnostics market in 2024. The regions covered in the allergy diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Request A Customized Version Of The Allergy Diagnostics Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=5655&type=smp

    Browse Through More Reports Similar to the Global Allergy Diagnostics Market 2025, By The Business Research Company

    Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

    Diagnostic Equipment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

    Antimicrobial Susceptibility Testing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/antimicrobial-susceptibility-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Allergy Diagnostics Industry Trends: Where the Market Is Headed by 2029

    Global Allergy Diagnostics Industry Trends: Where the Market Is Headed by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    How Much Was The Allergy Diagnostics Market Worth In 2025, And What Is Its Anticipated Value By 2029?

    The allergy diagnostics market has seen substantial growth in recent years. It is anticipated to expand from $6.32 billion in 2024 to $6.99 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.7%. The historical increase in this market can be linked to factors such as a rise in the prevalence of allergies, investments in research and development of allergy diagnostics, shifts in dietary habits and environmental factors, government initiatives, and an escalating demand for personalized medicine.

    The allergy diagnostics market is projected for significant expansion over the coming years. It is anticipated to reach $11.54 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 13.3%. Factors driving this growth during the forecast period include economic progress, an expanding healthcare infrastructure, an increasing aging population, and a heightened focus on early diagnosis and prevention. Key trends anticipated within this period encompass molecular allergy diagnostics, personalized allergen profiles, at-home allergy testing kits, the incorporation of artificial intelligence (AI), telemedicine, and virtual allergy consultations.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5655&type=smp

    What Are The Key Drivers Of Growth In The Allergy Diagnostics Market?

    The escalating incidence of allergic conditions is set to fuel expansion within the allergy diagnostics market. This surge in allergies is linked to heightened environmental pollution stemming from vehicular traffic and various industrial activities. An allergic reaction itself constitutes an atypical immune system response when exposed to a specific allergen. Such conditions encompass anaphylaxis, allergic rhinitis (commonly known as ‘hay fever’), various food allergies, skin allergies, and allergic asthma. The primary method for managing allergic disorders involves avoiding the identified allergen. Consequently, accurate allergy diagnosis becomes indispensable for administering successful treatment. For example, data from the American College of Allergy, Asthma, and Immunology (ACAAI) indicates that asthma and allergic ailments were prevalent across all age demographics in the US. In the US, asthma impacted 24 million individuals, a figure that included over 6 million children. Allergies ranked as the 6th leading cause of illness, incurring approximately $18 million in additional expenses. Annually, more than 50 million Americans experience allergies. Therefore, the increasing prevalence of allergic diseases will continue to bolster the growth of the allergy diagnostics market.

    What Are The Key Segments In The Allergy Diagnostics Market?

    The allergy diagnosticsmarket covered in this report is segmented –

    1) By Test Type: In-vivo Allergy Tests; In-vitro Allergy Tests

    2) By Allergen: Inhaled Allergens; Food Allergens; Drug Allergens

    3) By Products: Consumables; Instruments; Luminometers

    4) By End User: Diagnostics Laboratories; Hospital-based Laboratories; Academic and Research Institutes

    Subsegments:

    1) By In-vivo Allergy Tests: Skin Prick Tests; Intradermal Tests; Patch Tests; Oral Food Challenge Tests

    2) By In-vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA); Radioallergosorbent Test (RAST); Component-Resolved Diagnostics (CRD); Basophil Activation Tests (BAT)

    What Are The Major Trends Driving The Growth Of The Allergy Diagnostics Market?

    A notable recent trend in the allergy diagnostics industry is the growing number of collaborations and partnerships among companies, with the aim of inventing new testing methods or improving existing ones. For instance, in August 2022, LifeMD, a US-based telehealth company, announced a strategic partnership between its wholly-owned subsidiary, Cleared, and Allergenis, a US-based predictive data analytics company. This strategic partnership is intended to leverage Cleared’s allergy telehealth expertise and Allergenis’ peanut allergy diagnostic blood test in the direct-to-customer channel.

    Who Are The Major Companies Operating In The Allergy Diagnostics Market?

    Major companies operating in the allergy diagnostics market include BioMerieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC., Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Alcon Laboratories Inc., Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Astra Biotech GmbH, Stallergenes Greer, Diagenics Limited, DST Diagnostische Systeme & Technologien GmbH, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Microtest Laboratories Inc., Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Symbiotix Biotherapies Inc., Eurofins Viracor Inc., VRL Laboratories

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    Which Region Is Expected To Witness The Fastest Growth In The Allergy Diagnostics Market?

    North America was the largest region in the allergy diagnostics market in 2024. The regions covered in the allergy diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Request A Customized Version Of The Allergy Diagnostics Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=5655&type=smp

    Browse Through More Reports Similar to the Global Allergy Diagnostics Market 2025, By The Business Research Company

    Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

    Diagnostic Equipment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

    Antimicrobial Susceptibility Testing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/antimicrobial-susceptibility-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Allergy Diagnostics Market Projected to Reach $11.54 Billion by 2029 at a CAGR of 13.3%

    Global Allergy Diagnostics Market Projected to Reach $11.54 Billion by 2029 at a CAGR of 13.3%

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Fast Is The Allergy Diagnostics Market Expected to Grow Between 2025 And 2029?

    In recent times, the market size for allergy diagnostics has exhibited a swift increase. The predicted growth trajectory sees it increasing from $6.32 billion in 2024 to $6.99 billion in 2025, with a compound annual growth rate (CAGR) of 10.7%. The significant growth during the historical phase is credited to factors like heightened prevalence of allergies, investments funnelled into the research and development of allergy diagnostics, alteration in dietary patterns and environmental influences, government-backed initiatives, and increased demand for personalized medical approaches.

    The market size for allergy diagnostics is anticipated to experience a swift expansion in the upcoming years. It is predicted to reach$11.54 billion by 2029 with a compound annual growth rate (CAGR) of 13.3%. Factors such as economic development, the enhancement of the healthcare system, the aging of the global population, and the focus on early disease detection and protection contribute to the market’s growth over the forecast period. Key trends during this period are expected to include molecular allergy diagnostics, personalized allergen profiles, home-use allergy testing kits, and the incorporation of artificial intelligence (AI), telemedicine, and virtual allergy consultations.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=5655&type=smp

    What are the Fundamental Drivers and Innovations Shaping the Allergy Diagnostics Market?

    Enhanced incidents of allergic diseases are set to accelerate the expansion of the allergy diagnostics market. The growth in allergy disorders can be accredited to the rise in environmental contamination resulting from traffic and various industries. An allergic reaction involves an unusual response from the immune system to a particular allergen. Allergic diseases range from anaphylaxis and allergic rhinitis, also known as ‘hay fever,’ to food allergies, skin allergies, and allergic asthma. The most critical remedy for allergic illnesses involves steering clear of the allergen, making accurate allergy diagnosis vital for effective treatment. For example, the American College of Allergy, Asthma, and Immunology (ACAAI) indicates that asthma and allergic diseases were widespread across all age brackets in the US. Asthma afflicted 24 million people, including over 6 million children. Allergies were the 6th leading cause of sickness and incurred a cost of approximately $18 million in surplus. More than 50 million American citizens were affected by allergies annually. Consequently, the surging prevalence of allergic diseases will provide additional support to the allergy diagnostics market growth.

    How Is the Allergy Diagnostics Market Segmented?

    The allergy diagnosticsmarket covered in this report is segmented –

    1) By Test Type: In-vivo Allergy Tests; In-vitro Allergy Tests

    2) By Allergen: Inhaled Allergens; Food Allergens; Drug Allergens

    3) By Products: Consumables; Instruments; Luminometers

    4) By End User: Diagnostics Laboratories; Hospital-based Laboratories; Academic and Research Institutes

    Subsegments:

    1) By In-vivo Allergy Tests: Skin Prick Tests; Intradermal Tests; Patch Tests; Oral Food Challenge Tests

    2) By In-vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA); Radioallergosorbent Test (RAST); Component-Resolved Diagnostics (CRD); Basophil Activation Tests (BAT)

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=5655&type=smp

    Which Regions Are Driving the Next Phase of the Allergy Diagnostics Market Growth?

    North America was the largest region in the allergy diagnostics market in 2024. The regions covered in the allergy diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    What Key Trends Are Shaping the Future of the Allergy Diagnostics Market?

    A recent trend in the allergy diagnostics market is an increase in collaborations and partnerships between companies aiming to create new testing techniques or improve existing ones. For instance, in August 2022, a strategic partnership was announced between LifeMD, an American telehealth company, and its entirely owned subsidiary, Cleared and Allergenis, an American predictive data analytics firm. This partnership intends to utilize Cleared’s expertise in allergy telehealth and Allergenis’ peanut allergy diagnostic blood test in the direct-to-customer channel.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

    How Is the Allergy Diagnostics Market Defined and What Are Its Core Parameters?

    Allergy diagnostics involves tests and procedures to identify specific allergens, such as foods, pollens, or chemicals, triggering allergic reactions. Its main goal is to detect allergens accurately, allowing healthcare providers to suggest appropriate treatments. This improves the management of allergic conditions.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5655

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model